Q32 Bio (QTTB) Operating Leases (2020 - 2026)

Q32 Bio's Operating Leases history runs 7 years deep, the most recent figure standing at $4.8 million for Q1 2026.

• In Q1 2026, Operating Leases fell 13.04% year-over-year to $4.8 million; the TTM figure through Mar 2026 stood at $4.8 million (down 13.04% YoY), while the FY2025 annual figure was $4.9 million, down 12.3% from the prior year.
• Operating Leases was $4.8 million for Q1 2026 at Q32 Bio, down from $4.9 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $28.3 million in Q3 2022 to a low of $4.8 million in Q1 2026.
• Historically, Operating Leases has averaged $14.1 million across 5 years, with a median of $6.1 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Operating Leases surged 144.67% in 2022, then plunged 78.19% in 2024.
• A 5-year view of Operating Leases shows it stood at $27.9 million in 2022, then sank by 77.62% to $6.2 million in 2023, then fell by 9.8% to $5.6 million in 2024, then retreated by 12.3% to $4.9 million in 2025, then dropped by 3.82% to $4.8 million in 2026.
• The last three Operating Leases figures came in at $4.8 million (Q1 2026), $4.9 million (Q4 2025), and $5.1 million (Q3 2025), per Business Quant data.